Fluorescent 1 and 2 cell embryos |
A single ES cell colony expressing Green Fluorescent Protein growing on a fibroblast feeder layer |
Microinjection of embryonic stem cells into a blastocyst |
Dr Ben Davies
Transgenic Core Head
Genetically modified models represent one of the most powerful methods of functional gene analysis in vivo. Furthermore, the ability to introduce specific mutations into the genome enables models of human disease to be generated, facilitating insights into the pathophysiology of disease and providing a model with which therapeutic strategies and diagnostic tools can be optimized.
Our group provides groups within Oxford University access to transgenic technologies both on a fee-for-service type arrangement and on a collaborative basis. Technologies offered include embryo microinjection, embryonic stem cell transfection, Knock-out/-in construct design and in vivo shRNA mediated gene Knock-down. In addition, embryo rederivation and cryoconservation services are offered to facilitate the management, transfer and security of genetically modified strains.
The research activity of the group is focused on the development of novel methodologies for the generation of genetically modified models. The aims being to improve the reliability of the technology and to reduce the animal cost of research involving genetically modified models.
Recent publications
-
Naturally sterile Mus spretus hybrids are suitable for the generation of pseudopregnant embryo transfer recipients
Journal article
Preece C. et al, (2024), Lab Animal
-
Increasing knock-in efficiency in mouse zygotes by transient hypothermia
Journal article
DAVIES B. et al, (2024), CRISPR Journal
-
Donor template delivery by recombinant adeno-associated virus for the production of knock-in mice.
Journal article
Duddy G. et al, (2024), BMC Biol, 22
-
Characterization of meiotic recombination intermediates through gene knockouts in founder hybrid mice.
Journal article
Davies B. et al, (2023), Genome Res, 33, 2018 - 2027
-
Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2
Journal article
Broadway-Stringer S. et al, (2023), Cells